Bionano Genomics announces lineup of content at ACMG

Bionano Genomics announced its participation in the American College of Medical Genetics and Genomics, ACMG, Annual Clinical Genetics Meeting 2024 with a broad range of content covering optical genome mapping’s utility for research areas including cancer, rare genetic disease and constitutional disorders. Erik Holmlin, PhD, president and chief executive officer of Bionano, added, “We are proud to debut our new high throughput system for OGM, Stratys, at ACMG this year, and to host sessions featuring customers from our Stratys early access program presenting data from work conducted on the system. Researchers and scientists continue to push forward cutting-edge research in the human genetics space and we believe the capabilities of the Stratys system will unlock even more exciting research advancements. We look forward to these customers sharing their findings with the ACMG community.”